The gap between the first and second doses of the Covishield COVID-19 vaccine has been increased to 12-16 weeks – from the existing six-eight weeks – the government said.
The decision comes at a time when India is facing a shortage of doses of both Covishield and Covaxin, particularly after expanding the immunisation drive to include everyone above the age of 18.
The government, however, clarified the decision has been taken based on real-life evidence, especially from the UK.
“The recommendation of the COVID-19 Working Group was accepted by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC), headed by Dr V K Paul, Member (Health), Niti Aayog, in its meeting.
However,No changes have been announced in dosage intervals for Covaxin, which remains at four to six weeks.
Also,Sputnik V coronavirus vaccine has arrived in India and is likely to be available in the market by next week.